A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

A fully implantable, bioabsorbable pacemaker has been developed that's capable of sustaining heart rhythms in animal and human donor hearts before disappearing over 5 to 7 weeks. Temporary pacing ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo ® Temporary Pacing Lead was featured in a ...

For permission requests, please contact NEJM Reprints at [email protected] Many physicians use prophylactic antibiotics during insertion of valvular prostheses or permanent pacemakers, but only ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

ORLANDO, FL — Transvenous pacemaker leads pose a number of potential challenges and risks, including serious infection, so several alternative strategies—such as subcutaneous leads in the case of ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., today announced the company’s key activities at the Transcatheter Cardiovascular Therapeutics (TCT) 2017 meeting, which will take place ...

Photo Credit: Adapted from Brown K. TCT 564: A new perspective: intracardiac echocardiographic guidance for the implantation of a left atrial appendage occluder device (Watchman) with a leadless ...

Patients receiving leadless pacemakers experience overall fewer short-term and mid-term complications than those receiving traditional transvenous pacemakers, a new study found. Patients receiving ...

NEW ORLEANS -- A leadless dual-chamber pacemaker with bidirectional wireless communication turned in very promising short-term results in patients with standard indications for dual-chamber pacing, ...

A Cleveland Clinic-led study shows that leadless pacemakers have fewer mid-term and short-term complications than traditional transvenous pacemakers. The study was recently published in Heart Rhythm. ...